Status:
UNKNOWN
SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)
Lead Sponsor:
University College, London
Collaborating Sponsors:
Francis Crick Institute
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to investigate SARS-CoV-2 susceptibility, transmission and disease severity in healthcare workers and patients. Residual specimens from an existing collection of samples in viral inact...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Individuals who have previously provided nasal throat swab samples for SARS-CoV-2 testing at the Crick COVID 19 Consortium Testing centre.
- ≥18 years of age
- To enrol in the SARS-CoV-2 positive cohort of the study, the participant should have a positive RT qPCR result
- Employees based at the participating sites including who had their serology and/or swab tested (for recruitment to Cohort B)
- Participants enrolled in other studies who had their samples processed by using the Crick COVID 19 Consortium Testing centre (for recruitment to Cohort C).
- Written informed consent (except Cohort A1)
Exclusion
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04750356
Start Date
January 27 2021
End Date
December 31 2024
Last Update
May 23 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ealing and Northwick Park hospital
London, United Kingdom
2
The Francis Crick Institute
London, United Kingdom
3
UCLH
London, United Kingdom